Flow Re-Direction Endoluminal Device X (FRED X)

· MicroVention-Terumo, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Flow Re-Direction Endoluminal Device X (FRED X), covering 2026-03-24 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study [NA]